4//SEC Filing
Levisetti Matteo 4
Accession 0001209191-23-043278
CIK 0001645460other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 12:33 PM ET
Size
5.4 KB
Accession
0001209191-23-043278
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-07-21+82,500→ 82,500 totalExercise: $4.20Exp: 2033-07-20→ Common Stock (82,500 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001962444
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 12:33 PM ET
- Size
- 5.4 KB